Andrew Cardno Leads a Seminar at IGA: Unraveling the Impact of Recent Cyber Attacks on Indian Gaming
March 27, 2024 14:26 ET
|
QCI
SAN DIEGO, March 27, 2024 (GLOBE NEWSWIRE) -- The 2024 Indian Gaming Tradeshow and Convention in Anaheim, California, is set to host a pivotal session on the pressing issue of cyber security within...
Aegion Announces Acquisition of Toncco
March 27, 2024 11:00 ET
|
Aegion Corp
Aegion Corporation today announced the acquisition of Toncco, an underground utilities company based in Ogden, Utah.
Global Animal and Pet Food Market Analysis 2018-2023 and Forecast 2024-2033 Featuring Profiles of Cargill, Nestle, New Hope Liuhe Co, Charoen Pokphand Foods, and Bunge
March 27, 2024 08:10 ET
|
Research and Markets
Dublin, March 27, 2024 (GLOBE NEWSWIRE) -- The "Animal And Pet Food Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering.The animal and pet food market has grown...
Aecon consortium selected to redevelop the Cyril E. King Airport and Henry E. Rohlsen Airport in the U.S. Virgin Islands
March 26, 2024 17:46 ET
|
Aecon Group Inc.
TORONTO, March 26, 2024 (GLOBE NEWSWIRE) -- Aecon Group Inc. (TSX: ARE) (“Aecon”) announced today that VIports Partners (“VIports”), an Aecon-led consortium, has been selected by the U.S. Virgin...
GTG Global Collaborations and Innovation Update
March 26, 2024 08:00 ET
|
Genetic Technologies Ltd
GTG Global Collaborations and Innovation Update
PracticeLink Announces Appointment of Christy Bray Ricks as Chief Strategic Officer
March 25, 2024 12:45 ET
|
PracticeLink
ST. LOUIS and HINTON, West Virginia, March 25, 2024 (GLOBE NEWSWIRE) -- AAPPR -- PracticeLink, the nation’s most trusted physician recruitment resource and home of the most widely used online...
OKYO Pharma Announces OK-101 Successfully Achieved Statistical Significance for Multiple Signs and Symptoms of Dry Eye Disease including Ocular Pain Relief in its First-in-Human Phase 2 Trial of OK-101
March 22, 2024 07:00 ET
|
OKYO Pharma LTD
OKYO Pharma Announces OK-101 Successfully Achieved Statistical Significance for Multiple Signs and Symptoms of Dry Eye Disease including Ocular Pain Relief
HUTCHMED Initiates Registration Stage of the ESLIM-02 Phase II/III Trial of Sovleplenib for Warm Antibody Autoimmune Hemolytic Anemia in China
March 21, 2024 20:00 ET
|
HUTCHMED (China) Limited
HONG KONG and SHANGHAI, China and FLORHAM PARK, N.J., March 22, 2024 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13) today announces that it has initiated the...
OKYO Pharma to Host Key Opinion Leader Event to Discuss New and Comprehensive Data from Phase 2 Dry Eye Disease Trial
March 21, 2024 07:00 ET
|
OKYO Pharma LTD
-Phase 2 OK-101 efficacy data to be released March 22nd, 2024- -KOL Event to be held on April 9th, 2024 at 12 PM ET- LONDON and NEW YORK, March 21, 2024 (GLOBE NEWSWIRE) -- OKYO Pharma Limited...
Brian Parrish COO of Osage Nation Announces Eye Opening Results from QCI College
March 20, 2024 15:18 ET
|
QCI
SAN DIEGO, March 20, 2024 (GLOBE NEWSWIRE) -- As more companies are leveraging the powerful capabilities of the QCI Enterprise Platform, QCI proudly introduces QCI College – a unique initiative that...